Another source of CXCL1 in breast tumors may be adipose-derived mesenchymal stem cells (MSC) [76], which increase CXCL1 expression under the influence of interleukin-1β (IL-1β) from breast cancer cells [77]. This evidence concerns the gene IL1B and breast carcinoma.